Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
PMRT reduces the risks of locoregional failure (LRF), any recurrence, and breast cancer mortality. Some patients are likely to have such a low risk of LRF that the absolute benefit of PMRT is outweighed by its potential toxicities.
